GLINORM

This brand name is authorized in Tunisia

Active ingredients

The drug GLINORM contains one active pharmaceutical ingredient (API):

1 Repaglinide
UNII 668Z8C33LU - REPAGLINIDE

Repaglinide is a short-acting oral secretagogue. Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning ฮฒ-cells in the pancreatic islets.

Read about Repaglinide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BX02 Repaglinide A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TN Direction de la Pharmacie et du Mรฉdicament Identifier(s): 9164181, 9164182, 9164183, 9164184

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.